Down‐regulation of CYTL1 attenuates bleomycin‐induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF‐β/CCN2 axis

Author:

Wang Yan1,Liu Chenxi1,Xie Yi2,Li Xiaomei1

Affiliation:

1. Department of Pathology, Shenzhen People's hospital(The Second Clinical Medical College Jinan University, The First Affiliated Hospital Southern University of Science and Technology Shenzhen China

2. Department of Pathology The People's Hospital of Longhua Shenzhen China

Abstract

AbstractIdiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by chronic inflammation, lung tissue fibrotic changes and impaired lung function. Pulmonary fibrosis 's pathological process is thought to be influenced by macrophage‐associated phenotypes. IPF treatment requires specific targets that target macrophage polarization. Cytokine‐like 1(CYTL1) is a secreted protein with multiple biological functions first discovered in CD34+ haematopoietic cells. However, its possible effects on IPF progression remain unclear. This study investigated the role of CYTL1 in IPF progression in a bleomycin‐induced lung injury and fibrosis model. In bleomycin‐induced mice, CYTL1 is highly expressed. Moreover, CYTL1 ablation alleviates lung injury and fibrosis in vivo. Further, downregulating CYTL1 reduces macrophage M2 polarization. Mechanically, CYTL1 regulates transforming growth factor β (TGF‐β)/connective tissue growth factor (CCN2) axis and inhibition of TGF‐β pathway alleviates bleomycin‐induced lung injury and fibrosis. In conclusion, highly expressed CYTL1 inhibits macrophage M2 polarization by regulating TGF‐β/CCN2 expression, alleviating bleomycin‐induced lung injury and fibrosis. CYTL1 could, therefore, serve as a promising IPF target.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3